Clinical progress after randomized on/off pacemaker treatment for hypertrophic obstructive cardiomyopathy

Europace

Volumn 1, Issue 2, 1999, Pages 77-84

  Kappenberger, L J ^a   Linde, C ^a   Jeanrenaud, X ^a   Daubert, C ^a   McKenna, W ^a   Meisel, E ^a   Sadoul, N ^a   Chojnowska, L ^a   Guize, L ^a   Gras, D ^a   Aebischer, N ^a   Gadler, F ^a  

^a NONE

Author keywords

Dual chamber pacing; Hypertrophic cardiomyopathy; Pacemaker; Quality of life; Randomized trial

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EXERCISE TOLERANCE; FEMALE; HEART OUTFLOW TRACT OBSTRUCTION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; DOUBLE-BLIND METHOD; EXERCISE TOLERANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; QUALITY OF LIFE; TREATMENT OUTCOME; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 0039257196     PISSN: 10995129     EISSN: None     Source Type: Journal    
DOI: 10.1053/eupc.1998.0024     Document Type: Article

References (28)

1. Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE. Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology and therapy. N Engl J Med. 316:1987;780-789.
2. Wigle ED, Sasson Z, Henderson MA. Hypertrophic cardiomyopathy: The importance of the site and extent of hypertrophy: a review. Progr Cardiovasc Dis. 28:1985;1-83.
3. Maron B, Gardin J, Flack J, Gidding S, Bild D. Assessment of the prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study. Circulation. 92:1995;785-789.
4. Maron BJ, Wolfson JK, Epstein SE, Roberts WC. Intramural 'small vessel', coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol. 8:1986;545-557.
5. Frenneaux MP, Counihan PJ, Caforio ALP, Chimakori T, McKenna WJ. Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy. Circulation. 82:1990;1995-2002.
6. McKenna W, Camm J. Sudden death in hypertrophic cardio-myopathy. Assessment of patients at high risk. Circulation. 80:1989;1489-1492.
7. Cecchi F, Olivotto I, Montereggi A, Santoro G, Dolara A, Maron BJ. Hypertrophic cardiomyopathy in Tuscany: Clinical course and outcome in an unselected regional population. J Am Coll Cardiol. 26:1995;1529-1536.
8. Harrison DC, Braunwald E, Glick G, Mason DT, Chidsey CA, Ross J Jr. Effects of beta-adrenergic blockade on the circulation, with particular references to observations in patients with hypertrophic subaortic stenosis. Circulation. 29:1964;84-98.
9. Hopf R, Kaltenbach M. 10-year results and survival of patients hypertrophic cardiomyopathy treated with calcium-antagonists. Z Kardiol. 76(Suppl 3):1987;137-144.
10. Sherrid M, Delia E, Dwyer ED. Oral disopyramid therapy for obstructive hypertrophic cardiomyopathy. Am J Cardiol. 62:1988;1085-1088.
11. Fananapazir L, Chang A, Epstein S, McAreavy D. Prognostic determinants in hypertrophic cardiomyopathy: prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic and electrophysiologic findings. Circulation. 85:1992;2149-2161.
12. Ten Berg JM, Suttorp MJ, Knaepen PJ, Ernst S, Vermeulen FEE, Jaarsma W. Hypertrophic obstructive cardiomyopathy: Initial results and long-term follow up after Morrow septal myectomy. Circulation. 90:1994;1781-1785.
13. Seiler C, Hess OM, Schoenbeck M. Long-term follow up of medical versus surgical therapy for hypertrophic cardio-myopathy: a retrospective study. J Am Coll Cardiol. 17:1991;634-642.
14. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet. 346:1995;211-213.
15. Hassenstein P, Wolter HH. Therapeutische Beherrschung einer bedrohlichen Situation bei der idiopathischen hypertrophischen Subaortenstenose. Verh Dtsch Ges Kreisl. 33:1967;242-246.
16. Page A, Boudaut R, Bemurat M, Clementy J, Levy S, Besse P. Importance of sequential atrioventricular pacing in obstructive myocardiopathy with atrioventricular block. Arch Mal Coeur. 72:1979;1253-1258.
17. Jeanrenaud X, Goy JJ, Kappenberger L. Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy. Lancet. 339:1992;1318-1323.
18. Fananapazir L, Epstein ND, Curiel RV. Longterm results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive sympto-matic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation. 90:1994;2731-2742.
19. Nishimura RA, Trusty JM, Hayes DL. Dual-chamber pacing for patients with hypertrophic cardiomyopathy: a prospective randomized double-blind crossover trial (Abstract). J Am Coll Cardiol. 29:1997;435-441.
20. Kappenberger L, Linde C, Daubert C. Pacing in hypertrophic obstructive cardiomyopathy. A randomized Crossover study. Eur Heart J. 18:1997;1249-1256.
21. Undén A, Schenek-Gustavsson K, Axelson P. Positive effects of increased nurse support for male patients after acute myocardial infarction. Quality of Life Research. 2:1993;121-127.
22. Wigle ED, Rakowsky H, Kimball BP, Williams WG. Hypertrophic cardiomyopathy, clinical spectrum and treatment. Circulation. 92:1995;1680-1692.
23. Gadler F, Linde C, Juhlin-Dannfelt A, Ribeiro A, Ryden L. Long-term effects of pacing in patients with hypertrophic cardiomyopathy without outflow tract obstruction at rest. Eur Heart J. 18:1997;636-642.
24. Prinzen FW, Augustijn CH, Allessi MA. The time sequence of electrical and mechanical activation during spontaneous beating and ectopic stimulation. Eur Heart J. 13:1992;535-543.
25. Prinzen FW, Augustijn CH, Arts T, Allessi MA, Reneman RS. Redistribution of myocardial fiber strain and blood flow by asynchronous activation. Am J Physiol. 258:1990;H300-8.
26. Posma J, Blanksma P, Van der Wall E, Vaalburg W, Crijns H, Lie K. Effects of permanent dual chamber pacing on myocardial perfusion in symptomatic hypertrophic cardiomyopathy. Heart. 76:1996;358-362.
27. Gras D, De Place C, Varin C, Leclercq C, Mabo P, Daubert C. Radiofrequency catheter ablation of AV junction to improve AV synchrony in obstructive hypertrophic cardio-myopathy treated by DDD pacing (Abstr.). PACE. 17:1994;745.
28. Knight C, Kurbaan A, Seggewiss H. Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy. Circulation. 95:1997;2075-2081.